Intensity Modulated Radiation Therapy (IMRT)
Customize your policy alerts
Sign up for Community Health Plan Washington Policy MC.CP.MP.69 alerts
Get alerted when Policy MC.CP.MP.69 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity criteria for IMRT for Medicare health plans affiliated with Centene Corporation in MAC jurisdictions lacking CMS/MAC full coverage criteria; intended for providers and prior authorization reviewers.
No material clinical or coverage changes in this revision.
Coverage Criteria for IMRT
Covered Indications
IMRT is medically necessary when ANY one of the following indications is present:
Policy I.A; pediatric solid tumors
Policy I.B
Policy I.C
Policy I.D
Policy I.E
Policy I.E.1
Policy I.E.2
Policy I.E.3
Policy I.E.4
Policy I.E.5
Policy I.E.6
Policy I.E.7
Policy I.E.8
The policy includes site-specific indications drawn from guideline sources such as ASTRO and NCCN but explicitly notes that the listed anatomical sites are not intended to be an all‑inclusive enumeration of possible uses. Reviewers and treating clinicians should consider the listed sites as representative examples where IMRT is commonly considered medically necessary, and recognize that other clinically justified uses may exist that are not enumerated in this policy.
Coverage of services described in this clinical policy is subject to the member’s specific benefit documents and the terms of the applicable contract. This policy is a guide to medical necessity and does not guarantee payment; coverage decisions and benefit administration remain subject to the member’s evidence of coverage, certificate of coverage, policy, contract of insurance, and applicable Health Plan administrative procedures.
Within the portion of the document provided there are no discrete procedure‑level statements labeling particular uses of IMRT as ‘‘not medically necessary.’’ Implicitly, applications of IMRT that do not meet any of the medical necessity criteria listed in the policy (for example, indications not included among the site‑specific or top‑level criteria) may be considered unsupported and therefore subject to denial under the Plan’s review processes.
Billing and Coding
| 77385 | Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; simple |
| 77386 | Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex |
| 77301 | Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications |
| 77338 | Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session. |
| G6016 | Compensator-based beam modulation treatment delivery of inverse planned treatment using three or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session |
Provider Actions, Prior Authorization & Documentation
Prior Authorization Required
Prior authorization is required when billing for IMRT delivery and IMRT planning codes. Requests for prior authorization must document that the indication meets one of the medical necessity criteria in this policy (e.g., age < 18 with a solid tumor; medically inoperable cancer where dose escalation is required; primary bone tumors; re-irradiation where cumulative critical-structure dose would exceed tolerance; or other site-specific indications listed in the policy).
- Prior authorization required for IMRT delivery and planning codes (see coding list)
- Requests must document how the case meets the policy medical necessity criteria
Required Coding and Clinical Documentation
Claims and authorization requests should reference the appropriate IMRT CPT/HCPCS codes and include supporting clinical documentation. Documentation should include diagnosis, treatment intent (curative vs palliative), prior radiation history (including cumulative doses to critical structures, if re-irradiation), treatment planning details (IMRT planning report, dose-volume histograms), and justification for IMRT vs alternative radiation techniques.
Denial Risk for Unsupported or Undocumented Indications
Requests that do not provide adequate clinical documentation linking the requested IMRT services to a listed medical necessity indication, or that lack required coding or treatment-planning documentation, are at risk for denial.
- Incomplete documentation or unsupported indications may result in denial of authorization or claim payment
Background and Clinical Context
Intensity‑modulated radiation therapy (IMRT) delivers beams in which the radiation intensity is varied across each treatment field, enabling simultaneous differential dosing within a target volume. This modulation permits creation of steeper dose gradients and more conformal dose distributions than conventional techniques, improving organ‑at‑risk sparing and dose homogeneity within the planning target volume (PTV). These technical capabilities make IMRT particularly useful for tumors adjacent to critical structures, for dose escalation where higher target doses are required, and for re‑irradiation scenarios where cumulative organ tolerance is a concern. Tradeoffs include increased sensitivity to patient or target motion and potential exposure of larger low‑dose volumes compared with simpler techniques.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.